Pfizer, Dexcel Take 2 Patents Off Table For Bench Trial
Drugmaker Pfizer and an Israeli competitor that is seeking to create a generic version of a Pfizer heart medication said Tuesday they have reached an agreement to remove two asserted patents...To view the full article, register now.
Already a subscriber? Click here to view full article